Management of idiopathic myelofibrosis
- 1 March 1987
- journal article
- review article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 9 (1) , 1-12
- https://doi.org/10.1111/j.1365-2257.1987.tb01375.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosisBritish Journal of Haematology, 1986
- CLINICAL EVIDENCE FOR 1,25-HYDROXYCHOLECALCIFEROL ACTION IN MYELOFIBROSISThe Lancet, 1984
- Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: The value of chromosomal studies in predicting response and survivalCancer, 1982
- ‘Early’ Splenectomy and Survival in Agnogenic Myeloid MetaplasiaActa Haematologica, 1981
- Splenectomy in Patients with Agnogenic Myeloid Metaplasia: an Analysis of 321 Published CasesBritish Journal of Haematology, 1979
- Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasiaInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Splenectomy in Hematologic DisordersNew England Journal of Medicine, 1972
- Ascites in myeloid metaplasia due to ectopic peritoneal implantationCancer, 1969
- Androgens and ErythropoiesisNew England Journal of Medicine, 1966
- MYELOFIBROSIS CLINICAL, HEMATOLOGIC AND PATHOLOGIC STUDY OF 110 PATIENTSThe Lancet Healthy Longevity, 1962